We work to be a globally recognised site of international importance in reducing the disease burden due to pneumonia and meningitis pathogens.
We focus on vaccine evaluation and accelerated implementational preparedness. We strive to achieve this through excellence in clinical field epidemiology, strengthening links with basic scientists (microbiology, immunology, molecular biology) and policy makers (including social and economic science) and through fostering the professional development of emerging public health scientists in the field of vaccinology.
In recognising the health inequities between low-middle income countries (LMICs) and high-income countries (HICs), we endeavour to identify and address obstacles to achieve optimal vaccine impact.
